New modalities: Innovations in peptides as biotherapeutics

Synopsis

Peptides as a drug modality offer several advantages over both traditional small molecules and biologics including improved tissue penetration, simpler more modular design characteristics, accessing previously intractable targets and reduced immunogenic risks. The advancement of peptides as therapeutics has been aided by the development of peptide drug conjugates, and this event brings together world class and cutting edge scientists in the fields of peptide and peptide macrocyclic drug and drug conjugate research. The event will give insights into the challenges posed and also the potential for these drugs to make a real world impact, and to interact with active researchers.

---

Attendees

This event will be of interest to academic and industrial scientists, interested in learning the latest innovations in the field of peptide and peptide macrocyclic drug and drug conjugate developments.

---

Confirmed speakers

Sir Gregory Winter, Medical Research Council (MRC) Laboratory of Molecular Biology
Dr Rob Young, Blue Burgundy Ltd
Dr Louise Walport, The Francis Crick Insititute
Professor Ali Tavassoli, Chief Scientific Officer and Co-Founder, Curve Therapeutics.
Dr Aurelien Bigot, Syngenta Crop Protection
Dr Gemma Mudd, Bicycle Therapeutics
Dr Elisabetta Bianchi, IRBM

---

Programme

The full programme will be confirmed in due course.

SCI’s Fine Chemicals Group are committed to promoting diversity and equality in the chemical sciences. We aim to identify high quality speakers for all our conferences with full inclusivity where attendees from all backgrounds are welcome. We are open to offering flexible presentation options. 

---

Sponsorship and exhibition information

For further information and prices, please email conferences@soci.org.

---

Call for posters

Opportunities are available for a limited number of posters. Interested applicants should send an abstract of maximum one A4 page or 300 words, indicating title and authors to: conferences@soci.org by Wednesday 31 January 2024 with the subject line “New modalities: Innovations in peptides as biotherapeutics – poster submission”. An abstract template can be downloaded here.

---

Venue and Contact

---

Booking Process/Deadlines

Booking terms and conditions

---

CPD Info

SCI Members attending this meeting are able to claim CPD points.

---

Organising committee

Beatriz Dominguez, SCI / Johnson Matthey
Mark Frigerio, SCI / Bicycle Therapeutics
Helen Horsley, SC I /UCB
Kenneth Ling, SCI / Syngenta
Sarah Major, SCI / Dark Blue Therapeutics

---